TP53 and acute myeloid leukemia: In conclusion, with NGS, we constructed a predictive nomogram including disease status pretransplant, pre-MRD, cytogenetic risk classification, and TP53 and FLT3-ITDhigh ratio mutations for CIR in AML patients after allo-HSCT.